(Q24245178)

1

object named as

GJE Rinkel

0 references

Valery Feigin

2

object named as

VL Feigin

0 references

author name string

WM van den Bergh

4

0 references

M Vermeulen

5

0 references

J van Gijn

Cochrane Database of Systematic Reviews

6

0 references

publication date

24 January 2005

0 references

published in

0 references

cites work

Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Early intervention with nimodipine in subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Effect of nimodipine on platelet function in patients with subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Nicardipine in the prevention of spasm-induced neurological deficits after subarachnoid hemorrhage: A dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Cerebrovascular autoregulation is resistant to calcium channel blockade with nimodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Possible prophylactic potential of HA1077, a Ca2+ channel antagonist and vasodilator, on chronic cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Study design and outcome measures in studies on aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Definition of initial grading, specific events, and overall outcome in patients with aneurysmal subarachnoid hemorrhage. A survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

Why do we need systematic overviews of randomized trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Dose escalation trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Effects of isoquinoline derivatives, HA1077 and H-7, on cytosolic Ca2+ level and contraction in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Prediction and prevention of delayed ischemic dysfunction after aneurysmal subarachnoid hemorrhage and early operation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021

Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000277.PUB2

7 January 2021